April 28th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to report that the South Okanagan producing facility, which will from hereon in be referred to as “Facility 1”, has now formally submitted an MMPR application to Department of Health Canada. As part of the months of preparations prior to the submission, Facility 1 engaged the services of specialist legal council, security, and consulting firms to ensure all areas of the Health Canada application criteria were met as fully as possible.
